---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-025893"
form_type: "8-K"
ticker: "BHVN"
cik: "0001935979"
company_name: "Biohaven Ltd."
filed_at: "2022-10-03T23:59:59+00:00"
generated_at: "2026-06-23T06:08:25.152712+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Biohaven Ltd. completes spin-off from RemainCo, appoints CFO and board

## Summary
- Spin-off effective Oct 3, 2022; shareholders received 1 Biohaven share per 2 RemainCo shares; 35,832,557 shares issued.
- Matthew Buten appointed CFO effective Sept 28, 2022.
- Board of directors named: Class I (Antonijevic, Heffernan, Hugin), Class II (Bailey, Childs, Gregory), Class III (Coric, Mehta).
- Adopted 2022 Equity Incentive Plan, Employee Share Purchase Plan, and Legacy Award Settlement Plan.
- Entered transition services, US distribution (Nurtec ODT) and outsourcing agreements with RemainCo and Pfizer.

## SEC filing metadata
- accession: 0001628280-22-025893
- form_type: 8-K
- ticker: BHVN
- cik: 0001935979
- company_name: Biohaven Ltd.
- filed_at: 2022-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.01, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/biohavenltd8-k1032022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-025893
- JSON: https://secwatch.observer/filing/0001628280-22-025893.json
- Plain text: https://secwatch.observer/filing/0001628280-22-025893.txt

## Key facts
- Executive change
  John Childs was appointed as Director at Biohaven Ltd..
  - Action: appointed
  - Role: Director
  source text: Designated as Class II directors, with initial terms expiring at the 2024 annual meeting of Biohaven shareholders: • Gregory Bailey • John Childs
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- Executive change
  Gregory Bailey was appointed as Director at Biohaven Ltd..
  - Action: appointed
  - Role: Director
  source text: Designated as Class II directors, with initial terms expiring at the 2024 annual meeting of Biohaven shareholders: • Gregory Bailey
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- Executive change
  Kishan Mehta was appointed as Director at Biohaven Ltd..
  - Action: appointed
  - Role: Director
  source text: Designated as Class III directors, with initial terms expiring at the 2025 annual meeting of Biohaven shareholders: • Vladimir Coric • Kishan Mehta
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- Executive change
  Matthew Buten was appointed as Chief Financial Officer at Biohaven Ltd..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On September 28, 2022, the Company appointed Matthew Buten as Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- Executive change
  Vladimir Coric was appointed as Director at Biohaven Ltd..
  - Action: appointed
  - Role: Director
  source text: Designated as Class III directors, with initial terms expiring at the 2025 annual meeting of Biohaven shareholders: • Vladimir Coric • Kishan Mehta
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- Executive change
  Robert Hugin was appointed as Director at Biohaven Ltd..
  - Action: appointed
  - Role: Director
  source text: Designated as Class I directors, with initial terms expiring at the 2023 annual meeting of Biohaven shareholders: • Irina Antonijevic • Michael T. Heffernan • Robert Hugin
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- Executive change
  Michael T. Heffernan was appointed as Director at Biohaven Ltd..
  - Action: appointed
  - Role: Director
  source text: Designated as Class I directors, with initial terms expiring at the 2023 annual meeting of Biohaven shareholders: • Irina Antonijevic • Michael T. Heffernan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- Executive change
  Julia Gregory was appointed as Director at Biohaven Ltd..
  - Action: appointed
  - Role: Director
  source text: Designated as Class II directors, with initial terms expiring at the 2024 annual meeting of Biohaven shareholders: • Gregory Bailey • John Childs • Julia Gregory
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm
- Executive change
  Irina Antonijevic was appointed as Director at Biohaven Ltd..
  - Action: appointed
  - Role: Director
  source text: The following persons were appointed as directors of Biohaven on September 28, 2022: Designated as Class I directors, with initial terms expiring at the 2023 annual meeting of Biohaven shareholders: • Irina Antonijevic
  evidence_url: https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.